In conclusion, Alpinetin has a protective effect on COPD, which can inhibit apoptosis and reduce the release of inflammatory factors by reducing the activities of TGF‐β1, TNF‐α, and α‐SMA. The gene discussed is ACTA1; the disease is chronic obstructive pulmonary disease.